From plasma to copay accumulators, IDF achieves advocacy wins
IDF advanced multiple advocacy issues in 2022 from securing specific public health guidance to combatting copay accumulators, marking significant wins for the primary immunodeficiency community.
Read MoreConnect with others through IDF Caretakers Support Group
Jodi Taub doesn’t hesitate when asked what’s at the forefront of people’s minds as they join in the discussion during the
Read MoreNIH clinical trial explores fecal transplant for CGD colitis
The National Institutes of Health is recruiting for the first-ever study on the effectiveness of fecal transplants on CGD-related colitis.
Read MoreUpdate - RSV, Colds, Flu, and COVID, Oh My…
Update: In addition to cold, flu, and COVID-19, respiratory syncytial virus (RSV) has also hit hard this year. Learn about RSV in those with primary immunodeficiency.
Read MoreIDF’s new office boasts convenience, flexibility, savings
IDF’s new office in Hanover, Maryland is situated near transportation hubs, accommodates large groups, and allows for in-person, virtual, or hybrid events.
Read More
